Women's Health News, Articles | Today's Clinical Lab

Advancing Syphilis Detection Through Rapid Testing

Orasure Technologies Inc

Learn how rapid testing initiatives are addressing diagnostic delays in pregnancy and supporting earlier intervention against congenital syphilis

Sickle cell disease is the most common inherited blood disorder and is marked by abnormally shaped red blood cells that can block blood vessels, leading to pain and infection.

Biomarker Can Help Predict Preeclampsia Risk in Women with Sickle Cell Disease

American Society of Hematology

Findings pave way for more effective pregnancy management in higher risk patient population

Mammograms can detect breast cancer early, often before a lump can be felt, which improves the chances of successful treatment and survival.

Missing First Screening Appointment Linked to Higher Risk of Breast Cancer Death

BMJ-British Medical Journal

Targeted measures needed to boost attendance among initial non-attenders and reduce mortality risk, say researchers

Adequate folate is essential for DNA formation and proper cell growth and development.

Excessive Folic Acid Intake in Pregnancy Linked to Gestational Diabetes

Flinders University

With pregnancy supplement use at an all-time high, researchers say it’s time to revisit guidelines

More than half of heart attacks in women under age 65 were caused by nontraditional factors.

Mayo Clinic Study Reveals Hidden Causes of Heart Attacks in Younger Adults, Especially Women

Mayo Clinic

Study highlights overlooked heart attack causes in adults under 65, challenging long-held beliefs and revealing risks of misdiagnosis

For patients with IBD, stopping medication leads to an increase in IBD symptoms, which can make their pregnancies high-risk.

First Global Guidelines for Pregnancy and Inflammatory Bowel Disease Developed

University of California - San Francisco

UCSF's Uma Mahadevan, MD, leads international consensus conference, with goal of improving treatment and outcomes for women with IBD and their children

ER+ breast cancers rely on estrogen to grow and are typically treated by endocrine therapies that block the effects of estrogen.

One Step Closer to Improving ER+ Breast Cancer Patients’ Response to Therapy

Baylor College of Medicine

The findings support further clinical studies to determine whether this marker may help identify patients who could benefit from CDK4/6 inhibitors

Researchers performed whole-exome sequencing of 21 uterine cancers that were associated with previous tamoxifen use, and compared their genetic makeup with those of non-tamoxifen-associated uterine cancers in published databases.

Why Breast Cancer Therapy Tamoxifen May Lead to Higher Risk of Uterine Cancer

Mass General Brigham

Study shows how tamoxifen may raise uterine cancer risk and points to a possible way to prevent it

For this study, Caris's AI model analyzed data from over 35,000 patients in the Caris clinico-genomic database.

AI Outperforms Traditional Biomarkers in Predicting Breast Cancer Immunotherapy Success

Caris Life Sciences

New study in Nature Communications highlights AI's role in transforming immunotherapy decisions and precision oncology

There are 6.5 million women living with endometriosis in the United States, yet it is still notoriously difficult to diagnose, with a definitive diagnosis taking an average of seven years.

First Blood Test for Endometriosis Now Available in the US

Kephera Diagnostics

Noninvasive diagnostic offers alternative to surgery and could reduce average 7-year delay in diagnosis for endometriosis

Women's Health